ACT CAPITAL MANAGEMENT, LLC - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 41 filers reported holding LEAP THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACT CAPITAL MANAGEMENT, LLC ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$233,000
-23.6%
265,0000.0%0.32%
-24.6%
Q2 2022$305,000
-34.3%
265,0000.0%0.43%
-13.0%
Q1 2022$464,000
-36.4%
265,000
+17.8%
0.49%
-6.8%
Q4 2021$729,000
+17.2%
225,000
+45.2%
0.53%
+63.7%
Q3 2021$622,000
+182.7%
155,000
+15.7%
0.32%
+185.0%
Q2 2021$220,000134,0000.11%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Perceptive Advisors 16,952,992$27,802,0000.18%
Opaleye Management Inc. 540,000$886,0000.15%
ACT CAPITAL MANAGEMENT, LLC 134,000$220,0000.11%
Artal Group S.A. 3,000,000$4,920,0000.10%
HHLR ADVISORS, LTD. 3,575,745$5,864,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 910,047$1,492,0000.04%
PERSONAL CFO SOLUTIONS, LLC 78,165$128,0000.03%
GSA CAPITAL PARTNERS LLP 122,401$201,0000.02%
Windsor Creek Advisors, LLC 46,955$77,0000.02%
Golden Green, Inc. 14,824$24,0000.02%
View complete list of LEAP THERAPEUTICS INC shareholders